SAM, G., H, v. S., M, H., HP, N., KA, R., E, H., & P, R. (2021). Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study. Scientific reports, 11(1), 2707. https://doi.org/10.1038/s41598-021-81662-1
Chicago Style (17th ed.) CitationSAM, Gernaat, von Stedingk H, Hassan M, Nilsson HP, Rodriguez-Wallberg KA, Hedayati E, and Rydberg P. "Cyclophosphamide Exposure Assessed with the Biomarker Phosphoramide Mustard-hemoglobin in Breast Cancer Patients: The TailorDose I Study." Scientific Reports 11, no. 1 (2021): 2707. https://doi.org/10.1038/s41598-021-81662-1.
MLA (9th ed.) CitationSAM, Gernaat, et al. "Cyclophosphamide Exposure Assessed with the Biomarker Phosphoramide Mustard-hemoglobin in Breast Cancer Patients: The TailorDose I Study." Scientific Reports, vol. 11, no. 1, 2021, p. 2707, https://doi.org/10.1038/s41598-021-81662-1.